The therapeutic value of "Essential" phospholipids
Pristautz, H.
Münchener Medizinische Wochenschrift 117(14): 583-586
1975
ISSN/ISBN: 0341-3098 PMID: 806790 Document Number: 87878
43 male and 30 female patients with various types of hyperlipemia were treated with Lipostabil, Lipostabil forte and 2 placebo preparations, each treatment lasting one month. The effect on the serum lipid level, lipoprotein electrophoresis, coagulation, coronary and peripheral vascular diseases, blood pressure and glucose tolerance was examined. Lipostabil caused a significant decrease of the serum triglyceride level in Type IV. To us, the use of "Essential" phospholipids alone does not appear to be sufficient for the drug therapy of hyperlipemia, but it might play a supporting role in the treatment.